mSHMT Antibodies

Santa Cruz Biotechnology features a diverse variety of mSHMT monoclonal antibodies for research in metabolic regulation and cellular function. mSHMT Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Methionine synthase homologue (mSHMT) plays a crucial role in the methionine cycle, which is essential for cellular methylation processes and the synthesis of important biomolecules. mSHMT drives the conversion of homocysteine to methionine, impacting cellular metabolism and overall health. Understanding mSHMT function is vital for elucidating its role in various diseases, including metabolic disorders and cancer. Research has shown that mSHMT activity influences numerous cellular pathways and metabolic processes. Investigating mSHMT expression patterns can reveal important insights into disease progression and potential therapeutic targets. The relationship between mSHMT and cellular metabolism continues to be an active area of scientific exploration. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of mSHMT's role in health and disease.